Drawing on practical experience, the authors examine key questions and answers about various aspects relating to the enhanced approach for analytical procedure lifecycle management.
Melissa Hanna-Brown
Advertisement
Melissa Hanna-Brown is external technology & collaborations lead at Pfizer.
Articles by Melissa Hanna-Brown
Three hypothetical analytical target profiles (ATPs) are provided, reflecting the current thinking of the the European Federation of Pharmaceutical Industries and Associations Analytical Lifecycle Management Team.
Advertisement
Latest Updated Articles
Analytical Procedure Lifecycle Management: Current Status and OpportunitiesPublished: December 2nd 2018 | Updated:
Three Examples of Hypothetical ATPsPublished: December 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development
5
